contact us krjpencn

뉴스현황

Our Events

현재 위치: > 뉴스현황 > Our Events > Medicilon held the P...

Medicilon held the Preclincial and IND Declaration Seminar in Chengdu, China

저자:medicilon   업로드:2019-01-10  조회수:

Medicilon held the Preclincial and IND  Declaration Seminar in Chengdu, China.

Medicilon held the Preclincial and IND Declaration Seminar in Chengdu, China.

Medicilon CEO Chun-Lin Chen

Medicilon CEO Chun-Lin Chen gave a speech during the seminar where he shared his experience on IND filling for both US and China.

Professor Shuangqing Peng

Professor Shuangqing Peng had a topic on New Drug Safety Evaluation Approach.

Dr. Baomin Xin

Dr. Baomin Xin, Medicilon VP of DMPK and BA, shared his experience on big molecule analytical approach and future trend, shifting from Pharma to Biopharma.

Dr. Fei Ma

Dr. Fei Ma, Executive Director of #DMPK,  introduced a new idea of DMPK, including the ideal DMPK research model, DMPK activities during #Drug discovery.

Professor Xiaodong Zhang

Professor Xiaodong Zhang is #Medicilon VP of #Toxicology.

Dr. Zheyi Hu

Dr. Zheyi Hu, Director of Pharmacology, shared his experience on oncology animal models.

이전:Happy Chinese New Year from Medicilon

다음에:Medicilon Has Successfully Passed External Quality Assessment!